In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders

Pediatrics

Volumn 137, Issue 2, 2016, Pages

  Gidaya, Nicole B ^a   Lee, Brian K ^a   Burstyn, Igor ^a   Michael, Yvonne ^a   Newschaffer, Craig J ^a   Mortensen, Erik L ^b  

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; ASTHMA; AUTISM; CAUSAL ATTRIBUTION; CHILD; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL TREATMENT; POPULATION BASED CASE CONTROL STUDY; PRECONCEPTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY; TREATMENT DURATION; CASE CONTROL STUDY; CHEMICALLY INDUCED; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; RISK FACTOR; STATISTICAL MODEL;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84958684831     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-1316     Document Type: Article

References (47)

1. Hellerstedt WL, McGovern PM, Fontaine P, Oberg CN, Cordes JE. Prenatal environmental exposures and child health: Minnesota's role in the National Children's Study. Minn Med. 2008;91(9):40-43
2. Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002;39(4):251-259
3. Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AE. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003;61(2A):181-185
4. Lam F, Gill P. beta-Agonist tocolytic therapy. Obstet Gynecol Clin North Am. 2005;32(3):457-484
5. de Heus R, Mulder EJ, Derks JB, Visser GH. Acute tocolysis for uterine activity reduction in term labor: A review. Obstet Gynecol Surv. 2008;63(6):383-388, quiz 405
6. Witter FR, Zimmerman AW, Reichmann JP, Connors SL. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2009;201(6):553-559
7. Rodier P, Miller RK, Brent RL. Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders? Am J Obstet Gynecol. 2011;204(2):91-94
8. Henry A, Kennedy D, Lowe S. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2010;203(4):e14; author reply e14-15
9. Olesen C, Thrane N, Nielsen GL, Sørensen HT, Olsen J; EuroMAP Group. A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes. Respiration. 2001;68(3):256-261
10. Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: A UK population-based study. Thorax. 2008;63(11):981-987
11. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol. 2003;111(4):736-742
12. Connors SL, Crowell DE, Eberhart CG, et al. beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol. 2005;20(11):876-884
13. Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C, Zimmerman AW. Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders. J Neurodev Disord. 2011;3(4):307-315
14. Kim SH, Ye YM, Hur GY, et al. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. Yonsei Med J. 2009;50(2):182-188
15. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch Pediatr Adolesc Med. 2005;159(2):151-157
16. Lyall K, Ashwood P, Van de Water J, Hertz-Picciotto I. Maternal immunemediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord. 2014;44(7):1546-1555
17. Woo AY, Xiao RP. β-Adrenergic receptor subtype signaling in heart: from bench to bedside. Acta Pharmacol Sin. 2012;33(3):335-341
18. Davidsen JR. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants. Dan Med J. 2012;59(8):B4501
19. Nandakumaran M, Gardey CL, Challier JC, Richard MO, Panigel M, Olive G. Transfer of Salbutamol in the human placenta in vitro. Dev Pharmacol Ther. 1981;3(2):88-98
20. Baker ER, Flanagan MF. Fetal atrial flutter associated with maternal betasympathomimetic drug exposure. Obstet Gynecol. 1997;89(5 pt 2):861
21. Bergman B, Bokström H, Borga O, Enk L, Hedner T, Wängberg B. Transfer of terbutaline across the human placenta in late pregnancy. Eur J Respir Dis Suppl. 1984;134:81-86
22. Slotkin TA, Baker FE, Dobbins SS, Eylers JP, Lappi SE, Seidler FJ. Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum. Brain Res Bull. 1989;23(4-5):263-265
23. Garofolo MC, Seidler FJ, Cousins MM, Tate CA, Qiao D, Slotkin TA. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res Bull. 2003;59(4):319-329
24. Rhodes MC, Seidler FJ, Abdel-Rahman A, et al. Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex. J Pharmacol Exp Ther. 2004;308(2):529-537
25. Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108(Suppl 3):511-533
26. Slotkin TA, Tate CA, Cousins MM, Seidler FJ. Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Brain Res Dev Brain Res. 2001;131(1-2):113-125
27. Perlow JH, Montgomery D, Morgan MA, Towers CV, Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol. 1992;167(4 Pt 1):963-967
28. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: A prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;102(4):739-752
29. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22-25
30. Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997;44(1):82-84
31. Lauritsen MB, Jørgensen M, Madsen KM, et al. Validity of childhood autism in the Danish Psychiatric Central Register: findings from a cohort sample born 1990-1999. J Autism Dev Disord. 2010;40(2):139-148
32. Lee D, Majumdar SR, Lipton HL, Soumerai SB, Hennessy S, Davis RL. Special applications of pharmacoepidemiology. In: Strom BL, Kimmel SE, eds. Textbook of Pharmacoepidemiology. Philadelphia, PA: John Wiley and Sons; 2013:399-445
33. Burstyn I, Sithole F, Zwaigenbaum L. Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Dis Can. 2010;30(4):125-134
34. Durkin MS, Maenner MJ, Meaney FJ, et al. Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One. 2010;5(7):e11551
35. Atladóttir HO, Pedersen MG, Thorsen P, et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics. 2009;124(2):687-694
36. Atladóttir HO, Thorsen P, Østergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40(12):1423-1430
37. Schendel D, Bhasin TK. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics. 2008;121(6):1155-1164
38. Giarelli E, Wiggins LD, Rice CE, et al. Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil Health J. 2010;3(2):107-116
39. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol. 2005;161(10):916-925; discussion 926-918
40. Daniels JL, Forssen U, Hultman CM, et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 2008;121(5). Available at: www.pediatrics.org/cgi/content/full/121/5/e1357
41. Bodnar LM, Siega-Riz AM, Simhan HN, Diesel JC, Abrams B. The impact of exposure misclassification on associations between prepregnancy BMI and adverse pregnancy outcomes. Obesity (Silver Spring). 2010;18(11):2184-2190
42. Gidaya NB, Lee BK, Burstyn I, Yudell M, Mortensen EL, Newschaffer CJ. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord. 2014;44(10):2558-2567
43. Artama M, Gissler M, Malm H, Ritvanen A; Drugs and Pregnancy Study Group. Nationwide registerbased surveillance system on drugs and pregnancy in Finland 1996-2006. Pharmacoepidemiol Drug Saf. 2011;20(7):729-738
44. Svedmyr N. Fenoterol: A beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy. 1985;5(3):109-126
45. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect. 2006;114(9):1438-1444
46. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55(7):508-514
47. Bakhireva LN, Schatz M, Jones KL, Chambers CD; Organization of Teratology Information Specialists Collaborative Research Group. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol. 2008;101(2):137-143